ATE206306T1 - Verwendung von 9,10-secocholesta-5,7,10(19)-trien-1,3-ol (alfacalcidol) - Google Patents

Verwendung von 9,10-secocholesta-5,7,10(19)-trien-1,3-ol (alfacalcidol)

Info

Publication number: ATE206306T1
Authority: AT; Austria
Prior art keywords: secocholesta; alfacalcidol; trien; cancer; alfacacidol
Prior art date: 1997-02-20

Application number

AT98910810T

Other languages

English (en)

Inventor

Paul Trouillas

Original Assignee

Paul Trouillas

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-02-20

Filing date

1998-02-20

Publication date

2001-10-15

1998-02-20 Application filed by Paul Trouillas filed Critical Paul Trouillas

2001-10-15 Application granted granted Critical

2001-10-15 Publication of ATE206306T1 publication Critical patent/ATE206306T1/de

Links

OFHCOWSQAMBJIW-AVJTYSNKSA-N alfacalcidol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C OFHCOWSQAMBJIW-AVJTYSNKSA-N 0.000 title 1
229960002535 alfacalcidol Drugs 0.000 title 1
208000003174 Brain Neoplasms Diseases 0.000 abstract 1
241000282414 Homo sapiens Species 0.000 abstract 1
206010058467 Lung neoplasm malignant Diseases 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
201000005202 lung cancer Diseases 0.000 abstract 1
208000020816 lung neoplasm Diseases 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1
238000005303 weighing Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Manufacture Of Tobacco Products (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Plant Substances (AREA)

AT98910810T 1997-02-20 1998-02-20 Verwendung von 9,10-secocholesta-5,7,10(19)-trien-1,3-ol (alfacalcidol) ATE206306T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9702247A FR2759586B1 (fr)	1997-02-20	1997-02-20	Medicament de type anticancereux comportant au moins a titre de principe actif du 1-alpha hydroxycalciferol ou alfacalcidol
PCT/FR1998/000347 WO1998036754A1 (fr)	1997-02-20	1998-02-20	Utilisation du 9,10-secocholesta-5,7,10(19)-trien-1,3-ol, ou alfacalcidol

Publications (1)

Publication Number	Publication Date
ATE206306T1 true ATE206306T1 (de)	2001-10-15

Family

ID=9504159

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98910810T ATE206306T1 (de)	1997-02-20	1998-02-20	Verwendung von 9,10-secocholesta-5,7,10(19)-trien-1,3-ol (alfacalcidol)

Country Status (15)

Country	Link
EP (1)	EP0981350B1 (de)
JP (1)	JP2001511818A (de)
KR (1)	KR20000075514A (de)
CN (1)	CN1248168A (de)
AT (1)	ATE206306T1 (de)
AU (1)	AU6505098A (de)
BR (1)	BR9807592A (de)
CA (1)	CA2282086A1 (de)
DE (1)	DE69801907D1 (de)
FR (1)	FR2759586B1 (de)
IL (1)	IL131502A0 (de)
NO (1)	NO993997L (de)
PL (1)	PL335190A1 (de)
TR (1)	TR199901998T2 (de)
WO (1)	WO1998036754A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2004026811A (ja) *	2002-04-30	2004-01-29	Kiyoshi Hashizume	ビタミンｄ３誘導体を含有する抗癌作用を増強させるための薬剤
GB201704909D0 (en)	2017-03-28	2017-05-10	Ldn Pharma Ltd	Cancer therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS57149224A (en) *	1981-03-13	1982-09-14	Chugai Pharmaceut Co Ltd	Tumor-suppressing agent
IL110117A0 (en) *	1994-06-24	1994-10-07	Univ Ben Gurion	Pharmaceutical compositions comprising vitamin-d analogs

1997
- 1997-02-20 FR FR9702247A patent/FR2759586B1/fr not_active Expired - Fee Related
1998
- 1998-02-20 TR TR1999/01998T patent/TR199901998T2/xx unknown
- 1998-02-20 KR KR1019997007573A patent/KR20000075514A/ko not_active Withdrawn
- 1998-02-20 AT AT98910810T patent/ATE206306T1/de not_active IP Right Cessation
- 1998-02-20 IL IL13150298A patent/IL131502A0/xx unknown
- 1998-02-20 JP JP53634498A patent/JP2001511818A/ja active Pending
- 1998-02-20 EP EP98910810A patent/EP0981350B1/de not_active Expired - Lifetime
- 1998-02-20 CA CA002282086A patent/CA2282086A1/fr not_active Abandoned
- 1998-02-20 BR BR9807592-6A patent/BR9807592A/pt not_active Application Discontinuation
- 1998-02-20 WO PCT/FR1998/000347 patent/WO1998036754A1/fr not_active Ceased
- 1998-02-20 DE DE69801907T patent/DE69801907D1/de not_active Expired - Lifetime
- 1998-02-20 PL PL98335190A patent/PL335190A1/xx unknown
- 1998-02-20 AU AU65050/98A patent/AU6505098A/en not_active Abandoned
- 1998-02-20 CN CN98802696A patent/CN1248168A/zh active Pending
1999
- 1999-08-19 NO NO993997A patent/NO993997L/no unknown

Also Published As

Publication number	Publication date
WO1998036754A1 (fr)	1998-08-27
EP0981350A1 (de)	2000-03-01
NO993997D0 (no)	1999-08-19
KR20000075514A (ko)	2000-12-15
EP0981350B1 (de)	2001-10-04
AU6505098A (en)	1998-09-09
PL335190A1 (en)	2000-04-10
FR2759586B1 (fr)	2000-01-14
FR2759586A1 (fr)	1998-08-21
CN1248168A (zh)	2000-03-22
BR9807592A (pt)	2000-02-22
DE69801907D1 (de)	2001-11-08
CA2282086A1 (fr)	1998-08-27
TR199901998T2 (xx)	1999-11-22
NO993997L (no)	1999-10-19
JP2001511818A (ja)	2001-08-14
IL131502A0 (en)	2001-01-28

Similar Documents

Publication	Publication Date	Title
PL342078A1 (en)	2001-05-21	Inhibition of raf kinase using symmetrical and dissymmetrical substituted dimethylureas
CS553490A3 (en)	1992-04-15	Transdermal therapeutic system
AP9801392A0 (en)	1998-12-31	Concentrated antibody preparation.
TR200001544T2 (tr)	2000-11-21	Yeni bileşikler.
FI950169L (fi)	1995-01-13	PTH:n ja PTHRP:n analogit, niiden synteesi ja käyttö osteoporoosin hoitoon
BG101966A (en)	1998-09-30	Application of 1l-agonist for the treatment of lack of urine retention
MX9704030A (es)	1998-02-28	1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
DE3578611D1 (de)	1990-08-16	Instrumente zur behandlung von verformten naegeln bei menschlichen patienten.
ATE227127T1 (de)	2002-11-15	Hochdosiertes chromtripicolinat zur behandlung von typ-ii-diabetes
WO1992012715A3 (en)	1992-09-03	The use of loperamide and related compounds for treatment of respiratory disease symptoms
MX9602442A (es)	1997-02-28	Un tratamiento con fluoroquinolona a dosis unica elevada.
NZ308516A (en)	1999-05-28	Transdermal therapeutic system (tts) for administering testosterone
AU3390995A (en)	1996-03-29	Novel implant and novel vector for the treatment of acquired diseases
ATE206306T1 (de)	2001-10-15	Verwendung von 9,10-secocholesta-5,7,10(19)-trien-1,3-ol (alfacalcidol)
PT81387A (en)	1985-11-01	Process for preparing pharmaceutical compositions containing 1--beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide useful for treating human viral disfases
EP0588477A3 (en)	1994-05-25	Medicinal composition comprising tcf-ii
GR3015462T3 (en)	1995-06-30	Dynamic redression splint for the therapy of the forefoot adduction.
HU9402578D0 (en)	1994-11-28	Medicament for treating or preventing cerebrovascular diseases
PT1001942E (pt)	2003-11-28	Poli-hidroxibutilpirazinas sua preparacao e medicamentos que as contem
NZ502022A (en)	2000-12-22	Shaped products for medical purposes formed from coral of species Acropora
GR3001850T3 (en)	1992-11-23	Expellants of phytopathogenic microbes
DE3374066D1 (en)	1987-11-19	N-acyl derivatives of peptides, their manufacture and use in combating diseases and means therefor
SE8704471L (sv)	1989-05-17	Solarium
AR245225A1 (es)	1993-12-30	Composiciones para el tratamiento de cuero.
UA7955A (uk)	1995-12-26	Спосіб лікування туберкульозу легенів

Legal Events

Date	Code	Title	Description
2002-04-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties